The training program of the Division of Renal Diseases and Hypertension at the University of Colorado Denver provides an integrated 3-4 year experience in clinical nephrology (one year) and academic research (2-3 years). The program is designed to prepare postdoctoral fellows for careers in academic renal medicine. By utilizing 3 different hospitals with varied populations (University of Colorado Hospital, Veterans Affairs Medical Center, and Denver Health Medical Center), the fellows'clinical training exposes the trainees to a great range of patients with parenchymal renal diseases, fluid and electrolyte disorders, acid-base disorders, hypertension, acute and chronic kidney disease, acute renal replacement therapies, and chronic dialysis (peritoneal and hemodialysis, both at home and in-center), and all medical aspects of transplantation. Thereafter the fellows choose to pursue their research training in the laboratory or clinical research group of any faculty member in the Division, or other Divisions with which we closely interact, such as rheumatology and immunology. The laboratories have modern, state of the art equipment and staff that provide the best possible research environment. The fellows can choose from a large number of laboratories or clinical investigation related projects. Major research areas include acute kidney injury and chronic kidney disease, glomerulonephritis, diabetic nephropathy, polycystic kidney disease, hypertension and vascular disease, fluid and electrolytes with emphasis on calcium-phosphate metabolism and vasopressin, metabolism and aging, and transplantation. Research encompasses wide possibilities from basic research involving molecular and cell biology, to translational research involving animal models, to clinical studies from epidemiology to interventional studies on endothelial function to genetic studies and large clinical trials. Fellow are encouraged to enter a program leading to a Masters or Ph.D. in human biology that further broadens the research options available to them. The fellowship training program chooses 4 trainees each year, all of who commit to at least 3 years of training and express interest in an academic career. Interviewees are chosen from applicants who have completed at least three years of postdoctoral training in internal medicine. This ensures that the individual is ready for his or her clinical training, which is then followed by their research training.
The Division of Renal Diseases and Hypertension training program provides training for renal fellows and postdoctoral scientists interested in pursuing academic careers in basic, translational or clinical research in the areas of kidney disease, hypertension and metabolic disorders, and dialysis and transplantation. Training physicians and scientists in the area of hypertension and kidney disease may lead to new discoveries and advances in treatment which can ultimately reduce the burdens of kidney disease and hypertension that currently affect more than 20 million and 70 million adults in the United States, respectively.
|Montford, John R; Lehman, Allison M B; Scobey, Micah S et al. (2016) Cytosolic phospholipase A2Î± increases proliferation and de-differentiation of human renal tubular epithelial cells. Prostaglandins Other Lipid Mediat 126:1-8|
|Renner, Brandon; Tong, Hua Hua; Laskowski, Jennifer et al. (2016) Annexin A2 Enhances Complement Activation by Inhibiting Factor H. J Immunol 196:1355-65|
|Stites, Erik; Le Quintrec, Moglie; Thurman, Joshua M (2015) The Complement System and Antibody-Mediated Transplant Rejection. J Immunol 195:5525-31|
|Combs, Sara A; Culp, Stacey; Matlock, Daniel D et al. (2015) Update on end-of-life care training during nephrology fellowship: a cross-sectional national survey of fellows. Am J Kidney Dis 65:233-9|
|Kanbay, Asiye; Inonu, Handan; Solak, Yalcin et al. (2014) Uric acid as a potential mediator of cardiovascular morbidity in obstructive sleep apnea syndrome. Eur J Intern Med 25:471-6|
|Combs, Sara; Berl, Tomas (2014) Dysnatremias in patients with kidney disease. Am J Kidney Dis 63:294-303|
|Lehman, Allison M B; Montford, John R; Horita, Henrick et al. (2014) Activation of the retinoid X receptor modulates angiotensin II-induced smooth muscle gene expression and inflammation in vascular smooth muscle cells. Mol Pharmacol 86:570-9|
|Das Evcimen, Net; King, George L (2007) The role of protein kinase C activation and the vascular complications of diabetes. Pharmacol Res 55:498-510|
|Proctor, Gregory; Jiang, Tao; Iwahashi, Mieko et al. (2006) Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes. Diabetes 55:2502-9|
|Gibney, Eric M; Casebeer, Adrianne W; Schooley, Lynn M et al. (2005) Cardiovascular medication use after coronary bypass surgery in patients with renal dysfunction: a national Veterans Administration study. Kidney Int 68:826-32|
Showing the most recent 10 out of 24 publications